Hepatitis

Related records

Broader conditions (9)

• Digestive system disorder
• Disease
• Disease by body system or component
• Disease by developmental or physiological process
• Endocrine system disorder
• Hepatobiliary disorder
• Human disease
• Inflammatory disease
• Liver disorder

Narrower conditions (26)

• Acute hepatitis B virus infection
• Acute hepatitis C virus infection
• Alcoholic hepatitis
• Autoimmune cholangitis
• Autoimmune hepatitis
• Autoimmune hepatitis type 1
• Autoimmune hepatitis type 2
• Autoimmune hepatitis type 3
• Chronic hepatitis B virus infection
• Chronic hepatitis C virus infection
• Drug-induced hepatitis
• Epstein-Barr virus hepatitis
• Fulminant viral hepatitis
• Giant cell hepatitis with autoimmune hemolytic anemia
• Granulomatous hepatitis
• Hepatic tuberculosis
• Hepatitis A virus infection
• Hepatitis B virus infection
• Hepatitis C virus infection
• Hepatitis D virus infection

Trials (381)

• "Pregnancy and Viral Infections: Impact on Pregnant Women and Their Children. French Prospective Cohort"
• 24 VS 48-WEEK TREATMENT WITH PEG-IFN ALPHA-2A IN PATIENTS WITH GENOTYPE 2/3 CHRONIC HEPATITIS C
• 3-year Follow-up Study in Patients Previously Treated With TMC435-Containing Regimen for the Treatment of Hepatitis C Virus Infection
• 4-Methylumbelliferone as a Treatment for Chronic HBV/HCV
• A Bidirectional Study in Exploring the Dynamic Changes of Plasma and Urine Metabolites of Liver Cancer
• A Clinical Trials to Evaluate the Efficacy and Safety of Tenofovir With and Without DWPUR001 in Patients With HBV
• A Controlled Prospective Study of Transfusion-Associated Hepatitis
• A Multicenter Prospective Clinical Cohort Study on the Pathogen Spectrum of Severe Hepatitis (Liver Failure) Complicated With Infection
• A Multicenter Study to Determine the Depth and Duration of Hepatitis B Surface Antigen (HBsAg) Reduction After Single or Multiple Doses of ARC-520, in Combination With Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
• A Network & Dyad HIV Prevention Intervention for IDU's - 1
• A Partial Randomized, Single-blind or Open-label, Dose-escalation With Multiple-dose Design Study to Evaluate the Pharmacokinetics of Acetaminophen and Its Toxic Metabolites With Panadol® and SafeTynadol® in Healthy Volunteers
• A Phase 1/2, Open-Label, Single and Multiple Ascending Dose Study of CRMA-1001 in Adults With Chronic Hepatitis B
• A Platform Study to Evaluate Investigational Therapies in Chronic Hepatitis B Infection
• A Randomized, Open-label, Single-dosing, 2X2 Crossover Study to Compare the Safety and Pharmacokinetics of BR-TND Tablet(Tenofovir Disoproxil) With Viread Tablet(Tenofovir Disoproxil Fumarate) in Healthy Male Volunteers
• A Safety and Efficacy Study of a Single or Double Dose of HEPLISAV™ Hepatitis B Vaccine in Adults With End-Stage Renal Disease
• A Safety and Efficacy Study of the Hepatitis E Vaccine in Nepal.
• A Single-Arm Study Evaluating the Efficacy of Liquid Acupuncture Therapeutics in Chronic Hepatitis B
• A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B
• A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis C
• A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

Approved drugs (1)

• Lamivudine

Drugs in development (16)

• AB-836 Phase 1
• Acetaminophen Phase 1
• Adefovir dipivoxil Phase 1
• Ademetionine Phase 3
• Bersacapavir Phase 1
• Bulevirtide Phase 3
• Fish oil triglycerides Phase 2
• Metformin Phase 2
• Peginterferon alfa-2A Phase 3
• Peginterferon alfa-2B Phase 3
• Peginterferon lambda-1A Phase 2
• Pioglitazone Phase 2
• Ribavirin Phase 3
• Telbivudine Phase 3
• Tenofovir disoproxil Phase 1
• Tenofovir disoproxil fumarate Phase 1